EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Overcoming the novel glycan–lectin checkpoints in tumor microenvironments for the success of the cross-presentation-based immunotherapy

Mannat Jain, Isha M Jadhav, Suyash Vinayak Dangat, Srinivasa Rao Singuru, Gautam Sethi, Eiji Yuba, Rajesh Kumar Gupta

Biomaterials Science · 2025

DOI: 10.1039/d4bm01732c ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2025. Verfasst von Mannat Jain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Protein Biochemistry Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Tathawade, Pune-411033,…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Polysaccharides, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 386 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Japan Society for the Promotion of Science, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(a) Two primary mechanisms for cross-presentation of internalized antigens: cytosolic and vacuolar pathways. (b) To enhance antigen presentation and generate T cell responses, glycans are multivalently presented on a range of nanocarrier systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentPolysaccharidesImmunotherapyNeoplasmsLectinsHumansAnimalsGlycosylationImmune Checkpoint InhibitorsLectins, C-Type

Substanzen

PolysaccharidesLectinsImmune Checkpoint InhibitorsLectins, C-Type

Autor:innen und Institutionen

  • Protein Biochemistry Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Tathawade, Pune-411033, Maharashtra, India. jainmannat193@gmail.com.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600, Singapore. phcgs@nus.edu.sg.
  • Department of Chemistry & Bioengineering, Graduate School of Engineering, Osaka Metropolitan University, 3-3-138 Sugimoto, Sumiyoshi-ku, Osaka-city, Osaka 558-8585, Japan. yuba@omu.ac.jp.

Förderung

  • Japan Society for the Promotion of Science
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Jain, M., Jadhav, I. M., Dangat, S. V., Singuru, S. R., Sethi, G., Yuba, E., & Gupta, R. K. (2025). Overcoming the novel glycan–lectin checkpoints in tumor microenvironments for the success of the cross-presentation-based immunotherapy. Biomaterials Science. https://doi.org/10.1039/d4bm01732c

Vancouver

Jain M, Jadhav IM, Dangat SV, Singuru SR, Sethi G, Yuba E, et al. Overcoming the novel glycan–lectin checkpoints in tumor microenvironments for the success of the cross-presentation-based immunotherapy. Biomaterials Science. 2025. doi:10.1039/d4bm01732c

BibTeX
@article{Jain2025,
  author = {Jain, Mannat and Jadhav, Isha M and Dangat, Suyash Vinayak and Singuru, Srinivasa Rao and Sethi, Gautam and Yuba, Eiji and Gupta, Rajesh Kumar},
  title = {Overcoming the novel glycan–lectin checkpoints in tumor microenvironments for the success of the cross-presentation-based immunotherapy},
  journal = {Biomaterials Science},
  year = {2025},
  doi = {10.1039/d4bm01732c}
}
Kostenlos starten →